6Haim N,Rosenblatt E,Wollner M,et al.Salvage therpy for nonHodgkin' s lymphphoma with a combination of dexamethasone,etoposide,ifosfamide and cisplatins[J].Cancer Chemother pharmacol,1992,30(3):243-244. 被引量：1
1Messori A, Vaiani M, Trippoli S, et al. Survival in patients with intermediate or high grade non-Hodgkin's lymphoma:meta-analysis of randomized studies comparing third generation regimens with CHOP [J]. Cancer, 2001,84(3): 303-307. 被引量：1
2Multani P, White CA, Grillo-Lopez A. Non-Hodgkin's lymphoma: review of conventional treatments [J]. Curr Pharm Biotechnol, 2001,2(4): 279-291. 被引量：1
3Laport GF, Williams SF. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma [J]. Semin Oncol, 1998,25(4) :503-517. 被引量：1
4Coiffier B. Effective immunocheotherapy for aggressive nonHodgkin's lymphoma [J]. Semin Oncol, 2004,31 (1 Suppl 2):7-11. 被引量：1
5Gisselbrecht C, Mounier N. Improing second-line therapy in aggressive non-Hodgkin's lymphoma [J]. Semin Oncol, 2004,31 (1 Suppl 2): 12-16. 被引量：1
6Kimby E, Brandt L, Nygren P, et al. A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma[J]. Acta Oncol, 2001,40(2-3): 198-212. 被引量：1
7Goss PE. New perspectives in the treatment of non-Hodgkin's lymphoma [J]. Semin Oncol, 1992, 19(6 Suppl 12) :23-30. 被引量：1
8Loehrer PJ Sr, Laurer R, Roth B J, et al. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide [J]. Ann Intern Med, 1988,109(7):540-546. 被引量：1
9Haim N, Rosenblatt E, Wollner M, et al. Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone,etoposide, ifosfamide and cisplatin [J]. Cancer Chemother Pharmacol, 1992,30 (3): 243-244. 被引量：1
10Haim N, Ben-Shahar M, Faraggi D, et al. Dexamethasone,etoposide, ifosfamide and cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma [J]. Cancer,1997,80(10): 1989-1996. 被引量：1
1Hagemeister FB.Teratment of relapsed aggressive lymphomas:regimens with and without high-dose therapy and stem cell rescue[J].Cancer Chemother Pharmacol,2002,49(Suppl 1):13-20. 被引量：1
3Park SH,Kim S,Ko OB,et al.ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma:a single center experience[J].Cancer Invest,2006,21(3):159-164. 被引量：1
